Marina P. Siakantaris

Athens, ESYE31 11527, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Clonal B-Cell Lymphocytosis of Marginal Zone Origin: Presenting Features, Clinical Evolution and Prognostic Factors.

Clonal B-Cell Lymphocytosis of Marginal Zone Origin: Presenting Features, Clinical Evolution and Prognostic Factors.

Journal: Cancers

Published: May 25, 2026

Real-world treatment patterns and outcomes in chronic lymphocytic leukemia: a multicenter retrospective study in Greece.

Real-world treatment patterns and outcomes in chronic lymphocytic leukemia: a multicenter retrospective study in Greece.

Journal: Annals of hematology

Published: April 26, 2026

Focus on Extremely Late Relapses in Hodgkin Lymphoma: A Single Center Analysis.

Focus on Extremely Late Relapses in Hodgkin Lymphoma: A Single Center Analysis.

Journal: Cancers

Published: February 01, 2026

Real-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.

Real-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.

Journal: American journal of hematology

Published: January 30, 2026

Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.

Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.

Journal: Cancers

Published: September 04, 2025

Acalabrutinib resistance in a CLL patient harboring a C515 mutation in the BTK-C isoform.

Acalabrutinib resistance in a CLL patient harboring a C515 mutation in the BTK-C isoform.

Journal: Leukemia & lymphoma

Published: June 16, 2025

Novel isolated mutations at the C515 residue of BTK in a CLL patient associated with acalabrutinib resistance.

Novel isolated mutations at the C515 residue of BTK in a CLL patient associated with acalabrutinib resistance.

Journal: Leukemia & lymphoma

Published: May 16, 2025

Optimally Delivered R-da-EPOCH Versus R-CHOP-21 in Primary Mediastinal Large B-Cell Lymphoma: A Real-Life Comparison in a Single Academic Center.

Optimally Delivered R-da-EPOCH Versus R-CHOP-21 in Primary Mediastinal Large B-Cell Lymphoma: A Real-Life Comparison in a Single Academic Center.

Journal: Cancers

Published: March 27, 2025

PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.

PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.

Journal: Journal of hematology & oncology

Published: February 10, 2025

Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders.

Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders.

Journal: Annals of hematology

Published: January 08, 2025

Clinical features, treatment options and outcomes in primary cutaneous B-cell lymphomas: a real-world, multicenter, retrospective study.

Clinical features, treatment options and outcomes in primary cutaneous B-cell lymphomas: a real-world, multicenter, retrospective study.

Journal: International journal of dermatology

Published: August 26, 2024

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study.

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 20, 2024

Showing 1-12 of 54

Last Updated: 09/26/2026